日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development of tCAP(N3): Affinity Peptide-Aided, pH-Triggered Strategy for Site-Specific Native IgG Modification

tCAP(N3)的开发:亲和肽辅助的pH触发策略用于位点特异性天然IgG修饰

Kawakami, Hiroko; Rafique, Abdur; Tsuda, Shugo; Nagashima, Asaki; Nohara, Yukie; Dozono, Naoki; Sakamoto, Ken; Masuda, Shun; Kiyoshi, Masato; Shibata, Hiroko; Ishii-Watabe, Akiko; Yoshiya, Taku; Ito, Yuji

Skin disorder within 30 days is a favorable prognostic factor in patients with lung squamous cell carcinoma treated with necitumumab plus gemcitabine and cisplatin: a sub-analysis of the NINJA study

30天内出现皮肤疾病是接受奈西妥单抗联合吉西他滨和顺铂治疗的肺鳞状细胞癌患者的良好预后因素:NINJA研究的亚组分析

Kinoshita, Fumihiko; Tanzawa, Shigeru; Misumi, Toshihiro; Yoshioka, Hiroshige; Miyauchi, Eisaku; Ninomiya, Kiichiro; Murata, Yasunori; Takeshita, Masafumi; Yamaguchi, Masafumi; Sugawara, Shunichi; Kawashima, Yosuke; Hashimoto, Kazuki; Mori, Masahide; Miyanaga, Akihiko; Hayashi, Anna; Tanaka, Hisashi; Honda, Ryoichi; Nojiri, Masafumi; Sato, Yuki; Yamamoto, Ken; Masuda, Ken; Kozuki, Toshiyuki; Kawamura, Takahisa; Suzuki, Takuji; Yamaguchi, Teppei; Asada, Kazuhiro; Tetsumoto, Satoshi; Tanaka, Hiroshi; Watanabe, Satoshi; Umeda, Yukihiro; Yamaguchi, Kakuhiro; Kuyama, Shoichi; Tsuruno, Kosuke; Misumi, Yuki; Kuraishi, Hiroshi; Yoshihara, Ken; Nakao, Akira; Kubo, Akihito; Yokoyama, Toshihiko; Watanabe, Kana; Seki, Nobuhiko

Distinct metastatic spread and progression patterns in patients treated with crizotinib for ROS1- and ALK-rearranged non-small cell lung cancer: a single-center retrospective study

接受克唑替尼治疗的 ROS1 和 ALK 重排非小细胞肺癌患者具有不同的转移扩散和进展模式:一项单中心回顾性研究

Tomoaki Nakamura, Tatsuya Yoshida, Yuki Takeyasu, Ken Masuda, Yuki Sinno, Yuji Matsumoto, Yusuke Okuma, Yasushi Goto, Hidehito Horinouchi, Noboru Yamamoto, Yuichiro Ohe

Concordance between cryobiopsy and forceps biopsy specimens in assessment of immunohistochemistry staining for non-small cell lung carcinoma

冷冻活检和钳子活检标本在非小细胞肺癌免疫组织化学染色评估中的一致性

Kanako Nishimatsu, Yuji Matsumoto, Jumpei Kashima, Tatsuya Imabayashi, Keigo Uchimura, Hideaki Furuse, Ken Masuda, Yuki Shinno, Yusuke Okuma, Tatsuya Yoshida, Yasushi Goto, Hidehito Horinouchi, Noboru Yamamoto, Takaaki Tsuchida, Yuichiro Ohe, Yasushi Yatabe

A lung adenocarcinoma patient with ROS1 fusion and NBN germline mutation achieves long progression-free survival from sintilimab combined with niraparib after failure of ROS1 inhibitors: a case report

一例 ROS1 融合和 NBN 种系突变的肺腺癌患者在 ROS1 抑制剂治疗失败后,通过信迪利单抗联合尼拉帕尼治疗获得长期无进展生存期:病例报告

Fangye Xu #, Chunmei Xiao #, Weijie Sun, Yuange He, Roberto Chalela, Ken Masuda, Paola Ulivi, Kai Shen, Qianwen Shao, Jiali Xu, Lianke Liu

Kawasaki Disease and Vaccination: Prospective Case-Control and Case-Crossover Studies among Infants in Japan

川崎病与疫苗接种:日本婴儿前瞻性病例对照研究和病例交叉研究

Murata, Kenji; Onoyama, Sagano; Yamamura, Kenichiro; Mizuno, Yumi; Furuno, Kenji; Matsubara, Keita; Hatae, Ken; Masuda, Kiminori; Nomura, Yuichi; Ohno, Takuro; Kinumaki, Akiko; Miura, Masaru; Sakai, Yasunari; Ohga, Shouichi; Fukushima, Wakaba; Kishimoto, Junji; Nakamura, Yosikazu; Hara, Toshiro

Expression of Bitter Taste Receptors in the Intestinal Cells of Non-Human Primates

非人灵长类动物肠道细胞中苦味受体的表达

Imai, Hiroo; Hakukawa, Miho; Hayashi, Misa; Iwatsuki, Ken; Masuda, Katsuyoshi

The extracellular volume status predicts body fluid response to SGLT2 inhibitor dapagliflozin in diabetic kidney disease

细胞外液容量状态可预测糖尿病肾病患者对SGLT2抑制剂达格列净的体液反应。

Ohara, Ken; Masuda, Takahiro; Morinari, Masato; Okada, Mari; Miki, Atsushi; Nakagawa, Saki; Murakami, Takuya; Oka, Kentaro; Asakura, Maki; Miyazawa, Yasuharu; Maeshima, Akito; Akimoto, Tetsu; Saito, Osamu; Nagata, Daisuke

Thoracoscopic anterior 'fissure first' technique for left lung cancer with an incomplete fissure

胸腔镜前路“先裂隙”技术治疗左肺癌伴不完全裂隙

Samejima, Joji; Mun, Mingyon; Matsuura, Yosuke; Nakao, Masayuki; Uehara, Hirofumi; Nakagawa, Ken; Masuda, Munetaka; Okumura, Sakae

Tri-chlorido-{meth-yl[4-(methyl-imino)-pent-2-en-2-yl]aza-nido-κ(2) N,N'}hafnium(IV)

三氯-{甲基-基[4-(甲基-亚氨基)-戊-2-en-2-基]氮杂-nido-κ(2) N,N'}铪(IV)

Ikeda, Ken; Masuda, Hideki